129. Managing Comorbidities and Co-Infections in Patients with HIV
Friday, October 6, 2017: 10:30 AM-12:00 PM
Room: 14AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • evaluate new approaches for preventing and treating STIs in HIV patients
  • assess the effects of HIV infections on neurologic functioning¬†
  • describe strategies for diagnosing and treating HPV in HIV patients

Target Audience: Academicians, Clinicians, Fellows, Healthcare workers, HIV clinicians, HIV specialists, Infectious diseases physicians, Investigators, Members-in-training, Nurses, Pharmacists, Public health practitioners, Researchers, Scientists, Vaccinologists

Tracks: Adult ID, Pediatric ID

Moderators:  Rajesh Gandhi, MD, FIDSA, Massachusetts General Hospital and Lori Gordon, PharmD, Louisiana State University Health Sciences Center

10:30 AM
HIV and STIs
Susan Phillip, MD, MPH

10:55 AM
HIV in the Brain
Shibani Mukerji, MD, PhD
11:20 AM
Timothy Wilkin, MD, MPH, FIDSA

11:45 AM

CME Credits: Maximum of 1.50 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-278-L02-P


R. Gandhi, Gilead: Educational grant to MGH , Educational grant
Merck: Educational grant to MGH , Educational grant
Viiv: Educational grant to MGH , Educational grant
Theratechnologies: Scientific Advisor , Consulting fee
EMD Serono: Consultant , Consulting fee

L. Gordon, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.